Sanofi Delivers 2017 Business EPS(1) in line with Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/23/2026
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- BofA's Hartnett sees dollar slump, risk selloff if bond intervention fails
- Applied Optoelectronics sets up $600M at-the-market stock offering
- Fannie Mae loses at least 10 senior executives amid departures - WSJ
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- Morgan Stanley course-corrects their semiconductor equipment outlook on demand
- One killed, three injured when man attacks Swedish school with sword
Sanofi (SNY) Reports Q4 EPS of EUR1.06
February 7, 2018 6:47 AM ESTSanofi (NYSE: SNY) reported Q4 EPS of EUR1.06, EUR0.09 worse than the analyst estimate of EUR1.15. Revenue for the quarter came in at EUR8.69 billion versus the consensus estimate of EUR8.67 billion.
Sanofi expects 2018 business EPS(1) to grow between 2% and 5%(7) at CER, including the... More
